Funds and ETFs Chugai Pharmaceutical Co., Ltd

4519

JP3519400000

Name	Weight	AuM	1st Jan change	Investor Rating
NOMURA NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY	6.57%	0 M€	+11.43%
NOMURA NEXT FUNDS MSCI JAPAN EMPOWERING WOMEN SELECT INDEX ETF - JPY	1.87%	0 M€	+16.78%
DAIWA ETF MSCI JAPAN EMPOWERING WOMEN INDEX ETF - JPY	1.59%	0 M€	+17.26%
NOMURA NIKKEI 225 EXCHANGE TRADED FUND ETF - JPY	1.53%	0 M€	+15.20%
DAIWA ETF-NIKKEI 225 ETF - JPY	1.32%	0 M€	+15.47%	-
GLOBAL X MSCI GOVERNANCE-QUALITY JAPAN ETF - JPY	1.28%	0 M€	+13.64%	-
MAXIS NIKKEI 225 ETF - JPY	1.22%	0 M€	+14.38%	-
NEXT FUNDS MSCI JAPAN COUNTRY ESG LEADERS INDEX EXCHANGE TRADED FUND - JPY	1.13%	0 M€	+16.37%
NEXT FUNDS SOLACTIVE JAPAN ESG CORE INDEX ETF - JPY	1.11%	0 M€	+13.17%
LYXOR MSCI JAPAN ESG LEADERS EXTRA (DR) UCITS ETF - DAILY HEDGED TO EUR - ACC - EUR	1.09%	51 M€	-.--%	-
LYXOR MSCI JAPAN ESG LEADERS EXTRA (DR) UCITS ETF - ACC - EUR	1.09%	174 M€	-.--%	-
NOMURA NIKKEI 300 INDEX EXCHANGE TRADED FUND ETF - JPY	1.08%	0 M€	+18.59%
DAIWA ETF MSCI JAPAN ESG SELECT LEADERS INDEX ETF - JPY	0.77%	0 M€	+15.66%
NOMURA NEXT FUNDS NOMURA ENTERPRISE VALUE ALLOCATION INDEX ETF - JPY	0.70%	0 M€	+16.56%
DAIWA ETF FTSE BLOSSOM JAPAN INDEX ETF - JPY	0.54%	0 M€	+17.82%
NOMURA NEXT FUNDS JPX-NIKKEI INDEX 400 ETF - JPY	0.51%	0 M€	+16.31%
MAXIS JPX-NIKKEI 400 ETF - JPY	0.51%	0 M€	+16.03%
CSIF (IE) MSCI WORLD ESG LEADERS MINIMUM VOLATILITY BLUE UCITS ETF B - USD	0.49%	0 M€	+7.50%
NZAM ETF TOPIX EX-FINANCIALS - JPY	0.44%	0 M€	+15.35%	-
DAIWA ETF TOPIX ETF - JPY	0.37%	0 M€	+16.52%	-
MAXIS TOPIX ETF - JPY	0.37%	0 M€	+15.51%	-
NOMURA TOPIX EXCHANGE TRADED FUND ETF - JPY	0.37%	0 M€	+16.43%
VANECK SUSTAINABLE WORLD EQUAL WEIGHT UCITS ETF - EUR	0.35%	0 M€	+8.46%
VANECK MULTI-ASSET BALANCED ALLOCATION UCITS ETF - EUR	0.24%	0 M€	+2.77%	-
RBC QUANT EAFE EQUITY LEADERS ETF - USD	0.14%	2 M€	+9.19%	-
RBC QUANT EAFE EQUITY LEADERS (CAD HEDGED) ETF - HEDGED CAD	0.14%	2 M€	-.--%	-
VANECK MULTI-ASSET CONSERVATIVE ALLOCATION UCITS ETF - EUR	0.14%	0 M€	+1.13%	-
SIMPLIFY DEVELOPED EX-US PLUS DOWNSIDE CONVEXITY ETF - USD	0.11%	10 M€	-3.35%	-

Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%). Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).

Sector

Pharmaceuticals

Calendar

2024-06-26 - Ex-dividend day for dividende intermédiaire

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Chugai Pharmaceutical Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

4,946 JPY

Average target price

6,021 JPY

Spread / Average Target

+21.74%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHUGAI PHARMACEUTICAL CO., LTD	-7.41%	52.06B
ELI LILLY AND COMPANY	+32.36%	695B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.40%	361B
MERCK & CO., INC.	+19.46%	330B
ABBVIE INC.	+3.50%	283B
ASTRAZENECA PLC	+16.90%	239B
NOVARTIS AG	+8.14%	204B
ROCHE HOLDING AG	-7.77%	198B
AMGEN INC.	+8.62%	168B

Other Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-10 am EDT			5-day change	1st Jan Change
4,946 ^JPY	+0.45%		-2.91%	-7.41%

May. 01	Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation	MT
Apr. 25	Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	MT